Evozyne Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
54
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$81M
- Investors
-
8
Evozyne General Information
Description
Operator of a data-driven evolution-based molecular engineering platform intended to create novel proteins with advanced functionality. The company's platform offers generative AI-driven design, experimental validation, iterative machine-learning refinement, and deep biological performance datasets, enabling pharmaceutical and biotechnology researchers to explore protein mechanisms, accelerate therapeutic discovery, and develop biologic treatments with enhanced specificity, stability and clinical potential.
Contact Information
Website
www.evozyne.comCorporate Office
- 2430 North Halsted Street
- Chicago, IL 60614
- United States
Corporate Office
- 2430 North Halsted Street
- Chicago, IL 60614
- United States
Evozyne Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 27-Sep-2023 | $81M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 21-Apr-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Evozyne Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Evozyne Comparisons
Industry
Financing
Details
Evozyne Competitors (38)
One of Evozyne’s 38 competitors is Deep Genomics, a Venture Capital-Backed company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| A-Alpha Bio | Venture Capital-Backed | Seattle, WA | ||||
| AbCellera Biologics | Formerly VC-backed | Vancouver, Canada | ||||
| GlycosBio | Venture Capital-Backed | Houston, TX | ||||
| BellBrook Labs | Venture Capital-Backed | Madison, WI |
Evozyne Patents
Evozyne Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4649492-A1 | Artificial intelligence (ai)-based protein engineering systems and methods for designing synthetic protein sequences | Pending | 11-Jan-2023 | ||
| US-20260221231-A1 | Artificial intelligence (ai)-based protein engineering systems and methods for designing synthetic protein sequences | Pending | 11-Jan-2023 | ||
| WO-2024151579-A1 | Artificial intelligence (ai)-based protein engineering systems and methods for designing synthetic protein sequences | Inactive | 11-Jan-2023 | G16B40/30 |
Evozyne Signals
Evozyne Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| In-Q-Tel | Not-For-Profit Venture Capital | Minority | ||
| NVentures (Santa Clara) | Corporate Venture Capital | Minority | ||
| NVIDIA | Corporation | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| Valor Equity Partners | Growth/Expansion | Minority |
Evozyne FAQs
-
When was Evozyne founded?
Evozyne was founded in 2019.
-
Where is Evozyne headquartered?
Evozyne is headquartered in Chicago, IL.
-
What is the size of Evozyne?
Evozyne has 54 total employees.
-
What industry is Evozyne in?
Evozyne’s primary industry is Biotechnology.
-
Is Evozyne a private or public company?
Evozyne is a Private company.
-
What is the current valuation of Evozyne?
The current valuation of Evozyne is .
-
What is Evozyne’s current revenue?
The current revenue for Evozyne is .
-
How much funding has Evozyne raised over time?
Evozyne has raised $135M.
-
Who are Evozyne’s investors?
In-Q-Tel, NVentures (Santa Clara), NVIDIA, OrbiMed, and Valor Equity Partners are 5 of 8 investors who have invested in Evozyne.
-
Who are Evozyne’s competitors?
Deep Genomics, A-Alpha Bio, AbCellera Biologics, GlycosBio, and BellBrook Labs are some of the 38 competitors of Evozyne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process